AXSOME THERAPEUTICS INC revenue breakdown overview

AXSOME THERAPEUTICS INC revenue for the last year amounted to 372.57 M EUR, the most of which — 372.57 M EUR — came from its highest performing source at the moment, Novel Therapies for the Management of Central Nervous System Disorders, the year earlier bringing 245.17 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought AXSOME THERAPEUTICS INC 365.29 M EUR, and the year before that — 178.69 M EUR.